Skip to content
MedsAcross

Medicine

Choline fenofibrate 45 mg delayed-release capsule

Available on requestPrescription onlyUS FDAGeneric name

Choline fenofibrate 45 mg delayed-release capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 86°F). Protect…

Key facts

Active ingredient (INN)
Choline fenofibrate
Brand
Sold under the generic name
Strength
45 mg
Dosage form
Delayed-release capsule
Route
Oral
Packs
90 capsules, 10 blister pack
Manufacturer
Macleods PharmaceuticalsIndia2 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C10AB11 Choline fenofibrate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
4 December 2013
Identifiers
RxCUI 828373, 828379DailyMed set ID b9a3f97c-9e31-4a5f-822f-c9d45e394493, af225492-73b0-49bb-b32f-5399c3c3ec6dNDC 68180-128, 33342-294Application ANDA200750, ANDA207796

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
90 capsule, delayed release in 1 bottle33342-294-10Macleods PharmaceuticalsIndia26 February 2024
10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack33342-294-12Macleods PharmaceuticalsIndia26 February 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 December 2008Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Choline fenofibrate

Clinical summary

Choline fenofibrate is a peroxisome proliferator receptor alpha agonist indicated as adjunctive therapy to diet, among other approved uses. It is available as delayed-release capsules for oral use. MedsAcross supplies Choline fenofibrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Choline fenofibrate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Choline fenofibrate 45 mg delayed-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.